Identification of reduced circulating haptoglobin concentration as a biomarker of the severity of pulmonary embolism: a nontargeted proteomic study.

Identification of reduced circulating haptoglobin concentration as a biomarker of the severity of pulmonary embolism: a nontargeted proteomic study.

Risk stratification of patients with pulmonary embolism (PE) may identify patients at high risk of early death who may benefit from more intensive surveillance or aggressive therapy. Nontargeted proteomics may identify biomarkers useful for the risk stratification of patients with acute symptomatic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: María Insenser, Rafael Montes-Nieto, M Ángeles Martínez-García, Elena Fernandez Durán, Carmen Santiuste, Vicente Gómez, Jeffrey A Kline, Héctor F Escobar-Morreale, David Jiménez
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/3b7bc2520dca4a0e922da4fc89948213
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares